Inhibitors of Histone Deacetylase Suppress the Growth of MCF-7 Breast Cancer Cells

Inhibitors of histone deacetylase are attracting increasing interest due to their influence on transcription, differentiation, and apoptosis. We have investigated two synthetic inhibitors 3 and 4 of histone deacetylase and the natural product inhibitor trichostatin A for their ability to suppress the growth of MCF-7 breast cancer cells and here present complete and improved synthetic procedures. The compounds show a dose dependent inhibition of growth with activities in the low micromolar and nanomolar range. Trichostatin shows cytocidal effects at 100 nM and still has activity comparable to cisplatin (0.5 μM) at 10 nM. Whereas the synthetic inhibitor 3 has cytocidal activity at 10 μM compound 4 shows a maximum of 40% growth suppression at that concentration.